Our findings showed the prognostic value of SLC1A5 in HCC and lower-grade glioma (LGG) and provided novel insights into the correlation of and mechanism active between SLC1A5 expression and tumor immunity. Here, SLC1A5 is linked to hepatocellular carcinoma.